PUBLISHER: Meticulous Research | PRODUCT CODE: 1518337
PUBLISHER: Meticulous Research | PRODUCT CODE: 1518337
Mass Spectrometry Market Size, Share, Forecast, & Trends Analysis by Offering [Instrument, Software], Technology [Quadrupole, LC MS, Ion Trap, GC MS, Time of Flight, MALDI], Application [Impurity, Clinical Testing], End User - Global Forecast to 2030
The mass spectrometry market is projected to reach $10.4 billion by 2030 at a CAGR of 8.3% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by advancements in mass spectrometry technology, increasing food safety concerns, increasing applications of mass spectrometry, increasing R&D expenditure by pharmaceutical and biotechnology companies, and the high reliability and sensitivity of mass spectrometers. However, the high costs of instruments restrain the growth of this market. The rising adoption of mass spectrometers in emerging markets is a significant opportunity for the players operating in this market. However, the lack of skilled professionals is a challenge impacting the growth of this market. Additionally, the rising adoption of portable mass spectroscopy devices is a prominent trend in the mass spectrometry market.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the mass spectrometry market are Agilent Technologies, Inc. (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Waters Corporation (U.S.), Perkin Elmer Inc. (U.S.), INFICON Holding AG (Switzerland), Pfeiffer Vacuum GmbH (Germany), LECO Corporation (U.S.), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), SCIEX (a subsidiary of Danaher Corporation) (U.S.), LECO CORPORATION (U.S.), and Advion, Inc. (U.S.).
Based on offering, in 2023, the instrument segment is expected to account for the largest share of the mass spectrometry market. The segment's large share is attributed to the instruments' large-scale analysis capabilities and capacity to study several molecules from the same or different structural family and detect specific metabolites of disease.
Based on technology, in 2023, the quadrupole mass spectrometry segment is expected to account for the largest share of the mass spectrometry market. The large share of the segment is attributed to the benefits offered by quadrupole mass analyzers in targeted and quantitative applications and quadrupole mass spectrometry's use in measuring one or more ions in a mixture. Furthermore, quadrupole mass spectrometry is fast, simple, and reliable and does not require a high vacuum.
Based on application, in 2023, the drug metabolism testing segment is expected to account for the largest share of the mass spectrometry market. The large market share of this segment is attributed to the increasing applications of mass spectrometry in drug testing, increasing pharmaceutical and biotechnology research, and the high usage of mass spectrometers in target validation.
Based on end user, in 2023, the pharmaceutical & biotechnology industry segment is expected to account for the largest share of the mass spectrometry market. The large market share of this segment is attributed to the increasing role of mass spectrometry in the drug discovery and development pipeline, the increasing adoption of mass spectrometry in metabolomics, proteomics, and analysis of clinical tissue samples, and mass spectrometers' ability to determine pharmacokinetic properties and compound structures.
An in-depth analysis of the geographical scenario in the mass spectrometry market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the mass spectrometry market. Further, in 2023, the U.S. is expected to account for the major share of the mass spectrometry market in North America. The large share of this market is primarily attributed to the increase in R&D expenditures in the pharmaceutical & biotechnology industries, favorable government initiatives supporting mass spectrometry-based research, and the high adoption of advanced technologies.
Mass Spectrometry Market Assessment-by Offering
Mass Spectrometry Market Assessment-by Technology
Mass Spectrometry Market Assessment-by Application
Note: Other applications include pesticide residue analysis, isotope ratio determination, protein identification, and carbon dating.
Mass Spectrometry Market Assessment-by End User
Note: Other end users include forensics, and the nutraceuticals and cosmeceutical industries.
Mass Spectrometry Market Assessment-by Geography